Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Beigene Ltd Ads
(NQ:
BGNE
)
301.28
USD
+12.06 (+4.17%)
Official Closing Price
Updated: 4:27 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Beigene Ltd Ads
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Second- or Third-line Non-Small Cell Lung Cancer
March 05, 2021
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that a supplemental...
From
Business Wire News Releases
Stocks Showing Improving Market Leadership: Beigene Earns 83 RS Rating
March 04, 2021
Beigene sees its Relative Strength Rating move into the 80-plus level.
From
Investor's Business Daily
Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia
March 02, 2021
Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia
From
Business Wire News Releases
BeiGene Announces Closing of Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan
February 26, 2021
BeiGene Announces Closing of Collaboration with Novartis to Develop & Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan
From
Business Wire News Releases
Assembly Biosciences Foregoes Vebicorvir Registration Studies For Chronic Suppressive Therapy
February 26, 2021
Assembly Biosciences Inc(NASDAQ:ASMB)will not initiatePhase 3 studies of vebicorvir (VBR, or ABI-H0731) as a ...
Tags
Market News
Hepatits A
BGNE
From
Benzinga
BeiGene Reports Fourth Quarter and Full Year 2020 Financial Results
February 25, 2021
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today reported recent business highlights,...
From
Business Wire News Releases
Stocks Showing Improving Market Leadership: Beigene Earns 84 RS Rating
February 24, 2021
Beigene shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.
From
Investor's Business Daily
Week In Review: Yuanxin Raises $465 Million For Online Healthcare Company Miaoshou Doctor
February 20, 2021
Beijing Yuanxin Technology raised $465 million in a Series E round to support its online/offline healthcare operations, known as Miaoshou Doctor. The company's latest round was led jointly by Sequoia...
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
February 17, 2021
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
From
Business Wire News Releases
BeiGene's US Application For BRUKINSA In A Type Of Lymphoma, Accepted For Review
February 17, 2021
The FDA has accepted for reviewBeiGene Ltd's(NASDAQ:BGNE) supplemental marketing application seeking approval ...
Tags
News
Biotech
FDA
From
Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
AMTI
DFFN
SESN
From
Benzinga
BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia
February 17, 2021
BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia
From
Business Wire News Releases
Two Days Worth of News
February 11, 2021
The Sterling fell against the dollar after rising most of February, which boosted the indexes.
Tags
ETFs
Stocks / Equities
From
Blogs - TalkMarkets
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
AVNS
PLXP
IBB
From
Benzinga
bye bye BGNE and Mexichem
February 09, 2021
After a bull run for 5 days the Dow-Jones is down today. But as usual the index is only part of the picture.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Roll Call
February 05, 2021
The week ended with a disappointment in hiring levels which failed to back up lower unemployment numbers from earlier this week.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Stock Squeeze Remnants
February 01, 2021
Nokia remains in focus, the only major ADR gaining from the gamestoppers.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Week In Review: Matridx Raises $32 Million For AI/CRISPR-Cas Pathogen Metagenomics Diagnostic Devices
January 30, 2021
Matridx Biotech of Hangzhou closed a $32 million Series B round to support its pathogen metagenomics devices. GenFleet Therapeutics raised $16 million in a Series B+ round for clinical trials of its...
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Freezing Friday
January 29, 2021
Today is a good day for being into non-US shares as well as homeland ones.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma
January 27, 2021
BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma
From
Business Wire News Releases
Stand Back!
January 27, 2021
The crazy market continues, fed by newbie investors ganging up on short-sellers.
Tags
ETFs
Stocks / Equities
Commodities
From
Blogs - TalkMarkets
Industrial Uncertainty
January 26, 2021
Healthcare is continuing its bipolar action.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
KRYS
Small Cap
AMTI
From
Benzinga
Trade War Coming
January 25, 2021
There is a trade war coming between Germany and the USA because of rivalry on stimulus for the COVID epidemic.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
EUSA Pharma and BeiGene Announce Acceptance of a Biologics License Application for SYLVANT® (Siltuximab for Injection) in China
January 25, 2021
EUSA Pharma (UK) Limited and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) today announced that the Biologics License Application (BLA) for SYLVANT® (siltuximab for injection) was accepted by the China...
From
Business Wire News Releases
Stocks That Hit 52-Week Highs On Friday
January 22, 2021
Before 10 a.m. ET Friday, 82 stocks hit new 52-week highs. Areas of Interest: PayPal Holdings (NASDAQ:PYPL) ...
Tags
RNLX
FSLF
SAII
From
Benzinga
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
January 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MBIO
BDSX
DTIL
From
Benzinga
3 Lesser-Known Biotech Stocks that are Surging
January 21, 2021
Biotechnology was one of the most popular sectors in 2020. The coronavirus pandemic drew attention to the sector due to the urgent need for COVID-19 testing supplies and a vaccine.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ZLAB
NTRA
STOK
From
Benzinga
First Week of March 19th Options Trading For BeiGene (BGNE)
January 19, 2021
Investors in BeiGene Ltd (BGNE) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BGNE options chain...
Tags
Stocks
From
Market News Video
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.